Endo scraps $190M deal for pharma firm
February 28, 2019 at 13:17 PM EST
The company blamed the collapse on delays in getting regulatory approval for the deal in India.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|